Skip to content

MiMedx Group MDXG Price / sales

Price / sales at other companies

IAR
Integra LifeSciencesIART
0.4×-0.6×
Artivion logo
ArtivionAORT
3.8×+1.2×
Solventum logo
SolventumSOLV
1.4×-0.2×
Vericel logo
VericelVCEL
5.6×-3.8×
Enovis logo
EnovisENOV
0.6×-0.4×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
1.7×+0.7×

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on the most recent quarter.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's price / sales?
MiMedx Group (MDXG) reported price / sales of 1.5× in Q1 2026.
How has MiMedx Group's price / sales changed year-over-year?
MiMedx Group's price / sales decreased by 52.6% year-over-year, from 3.2× to 1.5×.
What is the long-term trend for MiMedx Group's price / sales?
Over 5 years (2020 to 2025), MiMedx Group's price / sales has grown at a -10.2% compound annual growth rate (CAGR), from 4.1× to 2.4×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.